Overview

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Clonidine Lauriad® to treat chemoradiation therapy induced severe oral mucositis in patients with head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Onxeo
Treatments:
Clonidine